US2017174700A1PendingUtilityA1
Biotin Derivatives
Est. expiryOct 29, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C08B 37/00C07D 495/04C07K 2317/20C09B 11/24C07D 403/12C07K 1/22G01N 33/6803C09K 11/06C07B 2200/11C09K 2211/1088C07K 2317/92C07K 1/13G01N 33/533G01N 33/58G01N 33/54353C09K 2211/1007G01N 33/582G01N 33/532C07K 16/42C12N 5/0636C12N 5/0638C12N 5/0637C07K 16/00G01N 33/569G01N 33/554A61K 2039/625G01N 33/53B01D 15/3823
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Biotin derivatives, methods of using the biotin derivatives and kits comprising the biotin derivatives.
Claims
exact text as granted — not AI-modified1 . A biotin derivative having structural formula (I):
wherein:
X is S or O;
R 1 is selected from H and a derivative group;
R 2 is selected from H and a derivative group;
Y is O or absent;
L is absent or is a linker;
R 3 is selected from —OR 4 , —COOR 4 , a reactive group, a protein, a peptide, an amino acid, a dextran, a monosaccharide, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a hormone, a lipopolysaccharide, a nucleotide, an oligonucleotide, a small molecule, a cell, a microplate, and a microparticle;
R 4 is selected from H and a derivative group;
wherein at least one of R 1 and R 2 is H;
wherein if X is O, at least one of R 1 and R 2 is not H, or Y is O;
or structural formula (II):
wherein:
X is S or O;
R is selected from H and a derivative group;
R 2 is selected from H and a derivative group;
L is absent or is a linker;
R 3 is selected from —OR 4 , —COOR 4 , a reactive group, a protein, a peptide, an amino acid, a dextran, a monosaccharide, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a hormone, a lipopolysaccharide, a nucleotide, an oligonucleotide, a small molecule, a cell, a microplate, and a microparticle;
R 4 is selected from H and a derivative group;
wherein at least one of R 1 and R 2 is H.
2 - 76 . (canceled)
77 . A composition comprising a biotin derivative of claim 1 and a solvent.
78 . (canceled)
79 . A method of immobilizing a biotin derivative to a solid support, comprising contacting a solid support with a biotin derivative of claim 1 , wherein the solid support comprises a biotin-binding moiety.
80 - 107 . (canceled)
108 . A method of detecting a protein in a sample, comprising the steps of:
a. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; b. providing a sample comprising a protein comprising a complementary group capable of reacting with the reactive group; c. providing a biotin-binding moiety comprising a detectable moiety; d. contacting the biotin derivative with the sample to provide a labeling mixture; e. contacting the labeling mixture with the biotin-binding moiety; and f. detecting the protein.
109 - 114 . (canceled)
115 . A method of detecting a protein in a sample, comprising the steps of:
a. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; and wherein the linker is present and comprises a detectable moiety. b. providing a sample comprising a protein comprising a complementary group capable of reacting with the reactive group; c. contacting the biotin derivative with the sample; and d. detecting the protein.
116 - 120 . (canceled)
121 . A method of isolating a protein in a sample, comprising the steps of:
a. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; b. providing a sample comprising a protein comprising a complementary group capable of reacting with the reactive group; c. providing a solid support comprising a biotin-binding moiety; d. contacting the biotin derivative with the sample to provide a labeling mixture; e. contacting the labeling mixture with the solid support; and f. allowing the protein to bind to the solid support to provide the isolated protein.
122 - 126 . (canceled)
127 . A method of isolating a cell in a sample, comprising the steps of:
a. providing a sample comprising at least one cell; b. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; c. providing an antibody comprising a complementary group capable of reacting with the reactive group and capable of binding to a protein on the cell; d. providing a solid support comprising a biotin-binding moiety; e. contacting the biotin derivative with the antibody to provide a biotin-labeled antibody; f. contacting the biotin-labeled antibody with the sample to provide a labeling mixture; g. contacting the labeling mixture with the solid support; and h. allowing the cell to bind to the solid support to provide the isolated cell.
128 - 132 . (canceled)
133 . A method of labeling a protein, comprising the steps of:
a. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; b. providing a sample comprising a protein comprising a complementary group capable of reacting with the reactive group; and c. contacting the biotin derivative with the sample to provide a biotin derivative-labeled protein.
134 - 137 . (canceled)
138 . The method of claim 133 , further comprising the steps of:
a. providing a biotin-binding moiety comprising a detectable moiety; and b. contacting the biotin-binding moiety with the biotin derivative-labeled protein.
139 . The method of claim 138 , wherein the biotin-binding moiety is selected from an avidin or a strepavidin.
140 . The method of claim 138 , wherein the detectable moiety is a chromophore, a fluorescent dye, a fluorescent protein, a nanocrystal, an enzyme, a molecule comprising an atom which is a radioisotope, or an atom which is a radioisotope.
141 . A method of labeling a protein in a sample, comprising the steps of:
a. providing a biotin derivative of claim 1 , wherein R 3 is a reactive group; and wherein the linker is present and comprises a detectable moiety; b. providing a sample comprising a protein comprising a complementary group capable of reacting with the reactive group; and c. contacting the biotin derivative with the sample to provide a labeled protein.
142 . The method of claim 141 , wherein the reactive group is an alkyne, and the complementary group is an azide.
143 . (canceled)
144 . The method of claim 141 , wherein the reactive group is an azide and the complementary group is an alkyne.
145 . (canceled)
146 . The method of claim 141 , wherein the detectable moiety is a chromophore, a fluorescent dye, a fluorescent protein, a nanocrystal, an enzyme, a molecule comprising an atom which is a radioisotope, or an atom which is a radioisotope.
147 . A method of labeling a biotin derivative comprising the steps of:
a. providing a biotin derivative of claim 1 ; b. providing a biotin-binding moiety; and c. contacting the biotin derivative with the biotin-binding moiety to provide the labeled biotin derivative.
148 - 149 . (canceled)
150 . A kit comprising a biotin derivative of claim 1 and a biotin binding moiety.
151 . The kit of claim 150 , wherein the biotin-binding moiety is selected from an avidin or a strepavidin.
152 . The kit of claim 150 , wherein the biotin-binding moiety comprises a detectable moiety.
153 . The kit of claim 149 , wherein the detectable moiety is a chromophore, a fluorescent dye, a fluorescent protein, a nanocrystal, an enzyme, or a radioisotope.Join the waitlist — get patent alerts
Track US2017174700A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.